Jump to content

βk-BDB

Add links
From Wikipedia, the free encyclopedia

βk-BDB
Clinical data
Other namesbk-BDB; MD-BP; 3′,4′-Methylenedioxy-2-aminobutanophenone
ATC code
  • None
Legal status
Legal status
  • Illegal in Russia, Japan
Identifiers
  • 2-Amino-1-(1,3-benzodioxol-5-yl)butan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H13NO3
Molar mass207.229 g·mol−1
3D model (JSmol)
  • CCC(C(=O)C1=CC2=C(C=C1)OCO2)N
  • InChI=1S/C11H13NO3/c1-2-8(12)11(13)7-3-4-9-10(5-7)15-6-14-9/h3-5,8H,2,6,12H2,1H3
  • Key:LPWAUWDHBUIFEE-UHFFFAOYSA-N

β-Keto-1,3-benzodioxolylbutanamine (βk-BDB) is a minor metabolite formed by N-demethylation of butylone (βk-MBDB).[1]

βk-BDB belongs to the substituted cathinones and substituted methylenedioxyphenylethylamines and can be characterized as an N-demethyl derivative of butylone, or as one of the possible homologues of methylone and ethylone, or as a beta-keto derivative of 1,3-benzodioxolylbutanamine (BDB).

See also

[edit source]

References

[edit source]
  1. ↑ Zaitsu K, Katagi M, Kamata HT, Kamata T, Shima N, Miki A, et al. (July 2009). "Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine". Forensic Science International. 188 (1–3): 131–139. doi:10.1016/j.forsciint.2009.04.001. PMID 19406592.
[edit source]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Βk-BDB&oldid=1368146890"